Reported about 8 hours ago
Eli Lilly, a leader in the pharmaceutical industry known for its weight-loss drugs Mounjaro and Zepbound, is highlighted as the top stock to buy right now. With consistent revenue growth and dividends, Lilly presents a strong investment opportunity. Despite facing some challenges from competitors, its robust product pipeline and commitment to shareholder returns make it an appealing option for long-term investors. Currently valued at 57 times forward earnings, investing in Lilly now could lead to significant growth and passive income in the future.
Source: YAHOO